摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3-Methylpiperidin-1-yl)(morpholin-4-yl)methanone

中文名称
——
中文别名
——
英文名称
(3-Methylpiperidin-1-yl)(morpholin-4-yl)methanone
英文别名
(3-methylpiperidin-1-yl)-morpholin-4-ylmethanone
(3-Methylpiperidin-1-yl)(morpholin-4-yl)methanone化学式
CAS
——
化学式
C11H20N2O2
mdl
MFCD02859859
分子量
212.29
InChiKey
VYDTVSFJMAGVDO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.909
  • 拓扑面积:
    32.8
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • Compounds for the treatment of inflammatory diseases
    申请人:Hoenke Christoph
    公开号:US20070259846A1
    公开(公告)日:2007-11-08
    Dihydrothienopyrimidines of formula 1 and the pharmacologically acceptable salts, enantiomers, racemates, hydrates, or solvates thereof, which are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin, or eyes, diseases of the peripheral or central nervous system or cancers, as well as pharmaceutical compositions which contain these compounds.
    化学式1的二氢噻嘧啶及其药理学上可接受的盐、对映体、消旋体、合物或溶剂合物,适用于治疗呼吸道或胃肠道不适或疾病、关节、皮肤或眼睛的炎症性疾病、外周或中枢神经系统疾病或癌症,以及含有这些化合物的药物组合物。
  • COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES
    申请人:HOENKE Christoph
    公开号:US20100197656A1
    公开(公告)日:2010-08-05
    Dihydrothienopyrimidines of formula 1 and the pharmacologically acceptable salts, enantiomers, racemates, hydrates, or solvates thereof, which are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin, or eyes, diseases of the peripheral or central nervous system or cancers, as well as pharmaceutical compositions which contain these compounds.
    公式1中的二氢噻唑嘧啶及其药理学上可接受的盐、对映体、消旋体、合物或溶剂化物,适用于治疗呼吸或胃肠疾病、关节、皮肤或眼睛的炎症性疾病、外周或中枢神经系统疾病或癌症,以及含有这些化合物的制药组合物。
  • Heterocyclic Compounds Which Modulate The CB2 Receptor
    申请人:Bartolozzi Alessandra
    公开号:US20110312944A1
    公开(公告)日:2011-12-22
    Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
    本发明揭示了调节CB2受体的化合物。根据本发明,这些化合物与CB2受体结合并作为激动剂,用于治疗炎症。那些作为激动剂的化合物还可用于治疗疼痛。
  • US7511045B2
    申请人:——
    公开号:US7511045B2
    公开(公告)日:2009-03-31
  • US7723341B2
    申请人:——
    公开号:US7723341B2
    公开(公告)日:2010-05-25
查看更多